---
title: "TRI-MIX PAPAVERINE 30/PHENTOLAMINE 1/PGE-1 2.5 INJ INJECTABLE, Rx only, Talon... — FDA record D-0205-2022 | Is It on Recall"
description: "Lack of assurance of sterility"
url: https://isitonrecall.com/recall/fda-drug-d-0205-2022-tri-mix-papaverine-30-phentolamine-1-pge-1-2-5-inj-injectable-rx-only-talon-compounding-pharmacy-295/
updated: 2026-10-01
site: "Is It on Recall"
language: en
---

[Recall archive](https://isitonrecall.com/archives/) / FDA drug enforcement

# TRI-MIX PAPAVERINE 30/PHENTOLAMINE 1/PGE-1 2.5 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oak... — FDA record D-0205-2022

Reported terminated

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Oct 12, 2021. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/).

## What the record says

- **Product**: TRI-MIX PAPAVERINE 30/PHENTOLAMINE 1/PGE-1 2.5 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
- **Reason**: Lack of assurance of sterility
- **Classification**: Class II
- **Recalling firm**: Vita Pharmacy, LLC dba Talon Compounding Pharmacy
- **Quantity**: 30 vials
- **Agency-reported status**: Terminated
- **Source record identifier**: D-0205-2022

[Open the official record](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0205-2022%22)

[What the recall classes mean](https://isitonrecall.com/guides/recall-classes/). Classification is an agency assessment, not individual medical advice.

## Lot and product identifiers

| Label field | Details supplied by the agency |
| --- | --- |
| Lot, code or applicability | Lot: 07222021:11 BUD: 11/30/2021; 08172021:72 BUD: 02/08/2022; 06282021:84 BUD: 10/23/2021; 07132021:93 BUD: 10/23/2021; 09102021:43 BUD: 02/08/2022 |

Match all identifying details in the current notice. A brand name alone is not enough.

## Distribution

United States including Washington, D.C. and Puerto Rico

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

- [Washington](https://isitonrecall.com/state/washington/)

## Dates in the source

- **Report date**: Nov 17, 2021
- **Recall initiation date**: Oct 12, 2021
- **Center classification date**: Nov 8, 2021
- **Termination date**: Oct 4, 2023

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

## What to do next

Read the official notice for the action that applies to your exact product.

[Read the current instructions](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0205-2022%22)

## Before changing a medicine

Follow urgent instructions in the current official recall notice. Speak to your pharmacist or prescriber before stopping or changing a prescribed medicine.

Talk to your doctor or pharmacist if you have questions or concerns about your medicine. [FDA medication recall guidance](https://www.fda.gov/drugs/drug-recalls/understanding-drug-recalls-what-know-and-what-do)

## Related records

[Medications records](https://isitonrecall.com/category/medications/) [Vita Pharmacy, LLC dba Talon Compounding Pharmacy records](https://isitonrecall.com/brand/vita-pharmacy-llc-dba-talon-compounding-pharmacy/)